Status:
UNKNOWN
A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families
Lead Sponsor:
Meharry Medical College
Conditions:
Human Papilloma Virus
HPV-Related Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The human papillomavirus (HPV) causes 90% of cervical cancers and is implicated in multiple other cancers. The HPV vaccine can prevent the vast majority of these cancers, but it is underused in adoles...
Detailed Description
The goal of this K01 application is to develop and pilot test an individually tailored, pre-visit health communication intervention targeting HPV-VH parents. The partnering clinic is Meharry Medical C...
Eligibility Criteria
Inclusion
- Aims 1 and 2 Only
- Inclusion Criteria
- Parents
- Parents of patients of MMC Pediatrics aged 11-18
- Refused HPV vaccination in the past two years
- Have not received any doses of HPV vaccine
- Own smartphone
- Speak English
- Have a clinic appointment scheduled within the coming month (AIM 1 Stage 2 \& AIM 2 only)
- Did not participate in Aim 1 Stage 1 (AIM 1 Stage 2 only)
- Did not participate in Aim 1 Stage 1 or Aim 1 Stage 2 (Aim 2 only)
- Providers
- Physicians, physician assistants, and nurse practitioners who deliver primary care to patients aged 11-18 (Aim 1 Stage 1)
- Physicians, physician assistants, and nurse practitioners who deliver primary care to patients aged 11-18 and the intervention at Meharry Medical College. (Aim 1 Stage 2, Aim 2)
- Exclusion Criteria:
- Parents
- Parents with vaccinated patients or never been offered the vaccine in MMC pediatrics aged 11-18
- Unvaccinated yet never refused the vaccine
- Do not speak English
- Do not own a smart phone
- Does not have an upcoming clinic visit (Aim 1 Stage 2 and Aim 2)
- Providers
- Providers: Physicians, nurse practitioners, and physician assistants who do not deliver primary care to pediatric patients aged 11-18 at Meharry and other clinics
- Providers who do not provide the HPV vaccine.
- Providers who do not participate in Aim 1 stage 1 (Aim 1 Stage 2 only)
- Did not pilot study (Aim 2)
Exclusion
Key Trial Info
Start Date :
February 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2024
Estimated Enrollment :
244 Patients enrolled
Trial Details
Trial ID
NCT04380623
Start Date
February 15 2021
End Date
May 30 2024
Last Update
September 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meharry Medical College
Nashville, Tennessee, United States, 37208